학술논문

Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial
Document Type
Article
Source
In: The Lancet Rheumatology. (The Lancet Rheumatology, September 2019, 1(1):e44-e54)
Subject
Language
English
ISSN
26659913